View Single Post
  #17  
Old Sat May 17, 2014, 01:20 AM
DanL DanL is offline
Member
 
Join Date: Dec 2010
Location: Denver, CO
Posts: 590
Here is an article that demonstrates the importance of 2 year survival after HCT. It is not specific to MDS, but MDS and AML are two of the blood cancers covered in the study. There are a few charts that do break down by disease after reviewing the article further.

http://www.ncbi.nlm.nih.gov/pubmed/21464398

Seems to point to an 80% return to normal life expectancy for MDS once the first two years are out of the way, which I think is pretty encouraging. Primary issues after two years - Relapse 9%, and non-relapse (probably includes GVHD along with other health and age related issues) 12%.
__________________
MDS RCMD w/grade 2-3 fibrosis. Allo-MUD Feb 26, 2014. Relapsed August 2014. Free and clear of MDS since November 2014 after treatment with Vidaza and Rituxan. Experiencing autoimmune attack on CNS thought to be GVHD, some gut, skin and ocular cGVHD. Neuropathy over 80% of body.
Reply With Quote